|
Mamedguseinova S.S., Kokorin V.A., Gordeev I.G.
Current opportunities of device-based treatment of arterial hypertension
|
№1 / 2019
|
|
Chulkov Vl.S., Vereina N.K., Chulkov V.S., Tarasova O.A., Sinitsyn S.P.
Hemostais, adipokines, rennin-angiotensin system gene polymorphisms and target organ damage in young patients with hypertension and abdominal obesity
|
№1 / 2019
|
|
Solovieva K.B., Shalenkova M.A., Dolbin I.V.
Estimating the compliance levels dynamic in hypertensive patients with first-second stage and first-third grades
|
№1 / 2019
|
|
Shulutko B.I., Makarenko S.V.
About comorbidity, entity of pathogenesis and optimization of internal diseases therapy
|
№1 / 2019
|
|
A.G. Evdokimova, E.V. Kovalenko, V.V. Evdokimov, K.I. Tebloev
The efficacy of angiotensin II receptors’ blockers use in patients wkth arterial hypertension and metabolic syndrome
|
№4 / 2018
|
|
L.A. Andreeva, L.A. Panchenkova, A.I. Martynov, E.A. Troshina, K.A. Khamidova, E.E. Kazanceva, L.A. Medvedeva, G.G. Karnuta, T.E. Yurkova
Dayly dynamics of indices of central aortic pressure and arterial stiffness in patients with arterial hypertension in the composition of a metabolic syndrome at the background of a fixed-dose combination of perindopril arginine and indapamide
|
№1 / 2018
|
|
N.P. Lyamina, A.V. Nalivaeva
Rational therapy of hypertensive crisis in the light of modern recommendations
|
№6 / 2017
|
|
S.N. Mammayev, KH.I. Ibragimova
Influence of antihypertensive therapy at endotheline-1 level in arterial hypertensive patients
|
№6 / 2017
|
|
A.G. Evdokimova, Е.V. Коvаlеnко, V.V. Evdokimov, К.I. Теblоеv, I.А. Shvetsova
Features of use of angiotensin receptor blockers in clinical practice (focus on candesartan)
|
№6 / 2017
|
|
G.A. Batishcheva, O.A. Mubarakshina, M.N. Somova, A.S. Yevstigneeva
Possibilities of fixed combination of nitrendipine and enalapril in the treatment of arterial hypertension
|
№6 / 2017
|
|
Ye.A. Yermakova, I.I. Kochergina
Features of course of arterial hypertension in patients with type 2 diabetes mellitus, its role in the development of vascular complications
|
№5 / 2017
|
|
A.G. Yevdokimova, Ye.S. Kiparisova, Ye.V. Kovalenko, V.V. Yevdokimov, L.I. Markova, K.I. Tebloev, I.V. Larina, A.I. Martynov
Рrevention and treatment of cognitive disorders in patients with hypertensive encephalopathy
|
№4 / 2017
|
Русский
